© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 93260 refers to a specific procedure known as programming device evaluation for an implantable subcutaneous lead defibrillator system. This procedure is conducted in person and involves a comprehensive assessment of the device's functionality. During the evaluation, iterative adjustments are made to the implantable device to ensure optimal performance. The process includes a thorough analysis and review conducted by a physician or another qualified healthcare professional, culminating in a written report detailing the findings and adjustments made. The patient is typically connected to an electrocardiogram (ECG) monitor to facilitate real-time monitoring of cardiac activity. This evaluation is crucial for determining the appropriate programmed values that will be permanently set in the device, ensuring that it functions effectively in managing the patient's cardiac health. The procedure encompasses various technical assessments, including the interrogation of stored data related to cardiac rhythms and episodes of tachyarrhythmia, as well as evaluations of pacing thresholds and potential issues with device integrity. Overall, this programming device evaluation is essential for optimizing the performance of the implantable subcutaneous lead defibrillator system and enhancing patient outcomes.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.